Canertinib CAS: 267243-28-7
MF: C24H25ClFN5O3
MW: 485.94
An irreversible pan-erbB tyrosine kinase inhibitor.

Canertinib (CAS 267243-28-7)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 101ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Ansökan Canertinib is an irreversible pan-erbB tyrosine kinase inhibitor
Momsregistreringsnummer :: 267243-28-7
Purity: ≥99%
Molecular Weight: 485.94
Molecular Formula: C24H25ClFN5O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

Canertinib is a potent and selective inhibitor of tyrosine residue phosphorylation of EGFR, blocking signal transgression and ceasing angiogenisis. Canertinib displays an IC50 = 1.5nM. Additionally, Canertinib's action in inhibiting EGFR increases apoptosis in cancerous cell lines in a titratable fashion.


Konferenser

Li, D., et al.: Oncogene, 27, 4702 (2008), Brown, A., et al.: Toxicol. Pathol., 36, 410 (2008), Chen, H., et al.: Chem. Biol. Drug Design, 71, 434 (2008),

Appearance :
Powder
Physical State :
Solid
Solubility :
Soluble in DMSO (2 mg/ml), methanol, ethanol (9 mg/ml), and water (<1 mg/ml).
LAGRING :
Store at room temperature
Melting Point :
175-180° C
Boiling Point :
~691° C at 760 mmHg (Predicted)
Density :
~1.4 g/cm3 (Predicted)
Refractive Index :
n20D 1.65 (Predicted)
IC50 :
EGFR: IC50 = 1.5 nM; ErbB2: IC50 = 9.0 nM
pK Values :
pKa: 12.09 (Predicted), pKb: 6.99 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
156414
Merck Index :
14: 1744
MDL Number :
MFCD09837878
SMILES :
C=CC(=O)Nc1cc2c(ncnc2cc1OCCCN1CCOCC1)Nc1ccc(F)c(Cl)c1

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Canertinib (CAS 267243-28-7)  Produkt Citat

See how others have used Canertinib (CAS 267243-28-7). Click on the entry to view the PubMed entry .

Citations 1 to 1 of 1 total

PMID: # 30462579  Paatero, I.|Veikkolainen, V.|Mäenpää, M.|Schmelzer, E.|Belting, HG.|Pelliniemi, LJ.|Elenius, K.| et al. 2019. Mol. Biol. Cell. 30: 209-218.

Citations 1 to 1 of 1 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 111ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 7ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.